altretamine has been researched along with Cystadenocarcinoma in 7 studies
Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.
Cystadenocarcinoma: A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty-six patients with recurrent ovarian cancer were reoperated, and cancer samples for the subrenal capsule assay (SRCA) were collected from 23 of them, whereas this test was not done in the remaining 23 control patients." | 2.67 | Subrenal capsule assay in selection of chemotherapy after operation for recurrent ovarian cancer. ( Venesmaa, P; Ylikorkala, O, 1991) |
| "Clinical investigation of epithelial ovarian cancer must involve the precise definition of the lesion, careful application of new techniques, the objective evaluation of such techniques, the comparison of results in a randomized fashion with prior forms of therapy, careful pathological evaluation of the tumour, and the evaluation of toxicity to the patient." | 2.65 | Mayo Clinic experience with epithelial ovarian cancer. ( Decker, DG, 1983) |
| "Thirty-eight women with advanced ovarian cancer resistant to alkylating-agent chemotherapy were treated with a combination of hexamethylmelamine and cisplatin." | 1.26 | Hexamethylmelamine and cisplatin in advanced ovarian cancer after failure of alkylating-agent therapy. ( Arseneau, JC; Davis, TE; Einhorn, N; Kaplan, BH; Pagano, M; Tunca, JC; Vogl, SE, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vogl, SE | 1 |
| Pagano, M | 1 |
| Davis, TE | 1 |
| Einhorn, N | 1 |
| Tunca, JC | 1 |
| Kaplan, BH | 1 |
| Arseneau, JC | 1 |
| Hernandez, E | 1 |
| Rosenshein, NB | 1 |
| Villar, J | 1 |
| Dillon, MB | 1 |
| Ettinger, DS | 1 |
| Order, SE | 1 |
| Brower, MS | 1 |
| Coleman, M | 1 |
| Pasmantier, MW | 1 |
| Silver, RT | 1 |
| Mamaril, AP | 1 |
| Quiguyan, CC | 1 |
| Decker, DG | 1 |
| Lund, B | 1 |
| Aabo, K | 1 |
| Rørth, M | 1 |
| Hansen, HH | 1 |
| Venesmaa, P | 1 |
| Ylikorkala, O | 1 |
| Mäenpää, J | 1 |
| Kangas, L | 1 |
| Grönroos, M | 1 |
2 trials available for altretamine and Cystadenocarcinoma
| Article | Year |
|---|---|
Mayo Clinic experience with epithelial ovarian cancer.
Topics: Adenocarcinoma; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; | 1983 |
Subrenal capsule assay in selection of chemotherapy after operation for recurrent ovarian cancer.
Topics: Adult; Aged; Altretamine; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclop | 1991 |
5 other studies available for altretamine and Cystadenocarcinoma
| Article | Year |
|---|---|
Hexamethylmelamine and cisplatin in advanced ovarian cancer after failure of alkylating-agent therapy.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Altretamine; Cisplatin; Cystadenocarcinoma; D | 1982 |
Alternating multiagent chemotherapy for advanced ovarian cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Altretamine; Antineoplastic Agents; Cisplatin; Cyclophosph | 1983 |
Treatment of advanced ovarian carcinoma with hexamethylmelamine, doxorubicin, and cis-platinum (HAC): results in both untreated and previously treated patients.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Altretamine; Antineoplastic Combined Chemotherapy Protocol | 1984 |
cis-Dichlorodiammineplatinum (II) and hexamethylmelamine in advanced ovarian carcinoma: a phase II study.
Topics: Adult; Aged; Altretamine; Cisplatin; Cystadenocarcinoma; Drug Evaluation; Drug Therapy, Combination; | 1982 |
Response of ovarian cancer to combined cytotoxic agents in the subrenal capsule assay: Part I.
Topics: Aclarubicin; Adolescent; Adult; Aged; Altretamine; Animals; Antibiotics, Antineoplastic; Antineoplas | 1985 |